RENAL INJURY AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN PATIENTS WITH OBESITY
ABSTRACT Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently the most prevalent cause of chronic hepatic disease worldwide. Recently, the association between MASLD and renal injury has emerged as an additional factor impacting the clinical course of MASLD. Obj...
Saved in:
| Main Authors: | Kellyane Dias CARVALHO, Cláudia DALTRO, Carla DALTRO, Helma Pinchemel COTRIM |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
2025-05-01
|
| Series: | Arquivos de Gastroenterologia |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032025000100503&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01) -
Emerging therapies and real-world application of metabolic dysfunction-associated steatotic liver disease treatment
by: Hee Yeon Kim, et al.
Published: (2025-07-01) -
Alnustone Ameliorates Metabolic Dysfunction‐Associated Steatotic Liver Disease by Facilitating Mitochondrial Fatty Acid β‐Oxidation via Targeting Calmodulin
by: Shourui Hu, et al.
Published: (2025-08-01) -
Association of estimated glucose disposal rate with risk of future metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases: a prospective cohort study
by: Yan Li, et al.
Published: (2025-07-01) -
Associations between circulating amino acids and metabolic dysfunction‐associated steatotic liver disease in individuals living with severe obesity
by: Ina Maltais‐Payette, et al.
Published: (2025-02-01)